Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


The UPC will decide whether to grant 10x Genomics a preliminary injunction against Nanostring on September 19
Samsung Bioepis’s biosimilar of a drug used to treat a rare blood disorder will remain on the German market
The Munich Regional Court has already granted a preliminary injunction restricting the sale of Amgen’s biosimilar version of orphan drug Soliris
Alexion obtained a preliminary injunction in Munich barring Amgen from selling a biosimilar version of its antibody drug